PHARMACOKINETICS
Case Narrative
Relevant Drug Information
The anti-thrombotic drug is a prodrug that is activated by cytochrome p450 2C19 to an active metabolite. The active metabolite inhibits the platelet receptor irreversibly, leading to a much longer duration of platelet inhibition than indicated by the very short elimination half-life of the active metabolite.
A 57 year old Indian man was seen in the cardiac clinic for occasional chest pain on effort. He was diagnosed has having stable ischaemic heart disease with angina pectoris. A decision was made to medicate him with an oral dose (75mg daily) of an anti-thrombotic drug. The patient is relatively well, moderately obese, but has no evidence of liver or renal impairment.
Multiple Oral Dose (Antithrombotic)
Would you like to see all the 20 patients in the population?
To go back to single patient view, please click "Back to first population" button, then click "Yes" button